CMS is preparing to conduct the Outpatient Prospective Payment System (OPPS) Drug Acquisition Cost Survey (ODACS) to collect specific acquisition costs for outpatient drugs and biologicals purchased by hospitals paid under the OPPS.
CMS' current bundling methodology for opioid use disorder (OUD) treatment payments does not accurately reflect care provided to Medicare enrollees, according to the Office of Inspector General (OIG).